Literature DB >> 22947128

Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma.

F Wang1, L-Y Shen, S-H Ma, N Li, Z Yang, K-N Chen.   

Abstract

To explore the value of positron emission tomography-computed tomography (PET-CT) scan in esophageal squamous cell carcinoma (ESCC), we retrospectively summarize the results of PET-CT scan from 118 patients, with ESCC who underwent PET-CT scan in the different courses during treatment. Then, the results of PET-CT scan plus other conventional methods were analyzed to identify the value of PET-CT scan in diagnosis, staging, response evaluation, monitoring recurrence, and metastasis following treatment. It is suggested that PET-CT scan possess high value in diagnosis and gives more favorable indication in N and M staging. PET-CT scan should be translated into routine surveillance for postoperation follow up and is one of more helpful evaluators of response to chemoradiotherapy or chemotherapy.
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  PET-CT; esophageal squamous cell carcinoma; metastasis; recurrence; response evaluation

Mesh:

Substances:

Year:  2012        PMID: 22947128     DOI: 10.1111/j.1442-2050.2012.01407.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  2 in total

1.  Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Authors:  Hiroyuki Yamada; Masao Hosokawa; Kazuo Itoh; Toshinao Takenouchi; Yoshihiro Kinoshita; Tomohiro Kikkawa; Keita Sakashita; Shion Uemura; Yasunori Nishida; Takaya Kusumi; Shigeyuki Sasaki
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

2.  Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Chenxue Jiang; Yun Chen; Yaoyao Zhu; Yapping Xu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.